Is Teladoc Oversold? (TDOC)

August 4, 2021

Is Teladoc Oversold? (TDOC)

A combination of weaker-than-expected earnings and swelling re-opening optimism caused shares of the telehealth company, Teladoc (TDOC), to fall by more than -50% from the ATH levels seen earlier this year. … But has the sell-off been overstated?
LikeFolio data still suggests a longer-term bullish outlook, as underlying Purchase Intent Mentions have remained significantly higher than 2019: +64% higher in 21Q2 (ended 6/30)

Although PI Mention volume declined -61% from last year's lockdown highs, that surge in usage may prove beneficial for long-term adoption...Generic Telehealth Mentions are trending +792% vs. 2019 (90-day moving average), demonstrating a lasting impact on consumer demand for such services.
Despite missing EPS estimates, Teladoc reported better-than-expected 21Q2 revenues last week and raised full-year guidance – After opening lower, TDOC shares rallied +14% in the following trading day.

Want deeper insights? Get Free Access to The Vault.

Related Posts

Monday Preview

83 companies in our coverage universe are set to report […]

Read More
5 Stocks to Watch This Week

Here are some key stats and data points on stocks […]

Read More
Mental Health Concerns are Fueling Telehealth Demand

Mental health and awareness surrounding the topic have grown significantly […]

Read More

Related Posts

About LikeFolio

LikeFolio analyzes social media data to accurately predict shifts in consumer behavior. We sell data and insights to professional investors, corporate research teams, and software providers.
© 2024
 LikeFolio. All Rights Reserved.